Beryl Drugs (BOM:524606) E10: ₹1.18 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524606 Beryl Drugs Ltd BOM:524606
70 GF Score
Price ₹24.04
GF Value ₹20.66
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Beryl Drugs E10?

Beryl Drugs BOM:524606 +7.85% 70 E10 is ₹1.18 as of Mar. 2026. GuruFocus rates BOM:524606 with a GF Score™ of 70/100 and a GF Value™ of ₹20.66 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Beryl Drugs's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹1.110. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹1.18 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Beryl Drugs's average E10 Growth Rate was 9.30% per year. During the past 3 years, the average E10 Growth Rate was 11.10% per year. During the past 5 years, the average E10 Growth Rate was 11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Beryl Drugs was 13.10% per year. The lowest was 9.20% per year. And the median was 11.10% per year.

As of today (2026-08-09), Beryl Drugs's current stock price is ₹24.04. Beryl Drugs's E10 for the quarter that ended in Mar. 2026 was ₹1.18. Beryl Drugs's Shiller PE Ratio of today is 20.37.

During the past 13 years, the highest Shiller PE Ratio of Beryl Drugs was 44.68. The lowest was 8.10. And the median was 18.95.


Beryl Drugs  (BOM:524606) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Beryl Drugs's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=24.04/1.18
=20.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Beryl Drugs was 44.68. The lowest was 8.10. And the median was 18.95.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Beryl Drugs E10 Related Terms


Beryl Drugs E10 Historical Data

* Premium members only.

The historical data trend for Beryl Drugs's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beryl Drugs E10 Chart

Beryl Drugs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.86 0.97 1.08 1.18

Beryl Drugs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.08 1.06 1.03 1.03 1.18

BOM:524606 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Beryl Drugs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beryl Drugs Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beryl Drugs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Beryl Drugs's Shiller PE Ratio falls into.


BOM:524606
70GF Score
Beryl Drugs Ltd BOM:524606
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beryl Drugs E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Beryl Drugs's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.11/164.2724*164.2724
=1.110

Current CPI (Mar. 2026) = 164.2724.

Beryl Drugs Quarterly Data

per share eps CPI Adj_EPS
201606 0.241 105.961 0.374
201609 0.202 105.961 0.313
201612 -0.176 105.196 -0.275
201703 -0.040 105.196 -0.062
201706 0.191 107.109 0.293
201709 1.070 109.021 1.612
201712 0.202 109.404 0.303
201803 1.728 109.786 2.586
201806 0.399 111.317 0.589
201809 0.280 115.142 0.399
201812 0.280 115.142 0.399
201903 0.200 118.202 0.278
201906 0.680 120.880 0.924
201909 0.340 123.175 0.453
201912 0.180 126.235 0.234
202003 -1.030 124.705 -1.357
202006 -0.390 127.000 -0.504
202009 0.960 130.118 1.212
202012 -0.340 130.889 -0.427
202103 0.230 131.771 0.287
202106 0.670 134.084 0.821
202109 -0.830 135.847 -1.004
202112 -0.200 138.161 -0.238
202203 -0.940 138.822 -1.112
202206 0.430 142.347 0.496
202209 0.670 144.661 0.761
202212 0.280 145.763 0.316
202303 0.120 146.865 0.134
202306 1.050 150.280 1.148
202309 0.540 151.492 0.586
202312 0.610 152.924 0.655
202403 -0.680 153.035 -0.730
202406 0.730 155.789 0.770
202409 0.010 157.882 0.010
202412 0.100 158.323 0.104
202503 0.300 157.552 0.313
202506 0.040 159.755 0.041
202509 0.020 162.289 0.020
202512 -0.020 163.281 -0.020
202603 1.110 164.272 1.110

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹1.18 mean?
Beryl Drugs (BOM:524606) has a E10 of ₹1.18 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Beryl Drugs and its competitors.
Is Beryl Drugs' E10 too high?
Beryl Drugs' current E10 is ₹1.18. Overall, Beryl Drugs has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Beryl Drugs' E10 compare to ZTS?
Beryl Drugs' E10 of ₹1.18 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Beryl Drugs and its competitors. Beryl Drugs's current E10 is ₹1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beryl Drugs stock overvalued right now?
Based on GuruFocus' analysis, Beryl Drugs (BOM:524606) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹20.66, compared to a current price of ₹24.04 — trading 16.4% above its estimated fair value. The current E10 is ₹1.18. Beryl Drugs' overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Beryl Drugs (BOM:524606), the current E10 is ₹1.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beryl Drugs (BOM:524606) Overvalued in 2026?

Based on GuruFocus' analysis, Beryl Drugs stock appears to be overvalued. The current stock price of ₹24.04 is trading 16.4% above its estimated GF Value™ of ₹20.66. GuruFocus considers Beryl Drugs to be Modestly Overvalued.

Key valuation signals for BOM:524606:

  • E10: ₹1.18
  • GF Value™: ₹20.66 vs. price of ₹24.04 (16.4% above fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the BOM:524606 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beryl Drugs Business Description

Address 133, Kanchan Bagh, Ground Floor, Indore, MP, IND, 452001
Beryl Drugs Ltd is a pharmaceutical company principally engaged in the manufacturing and marketing of allopathic pharmaceutical preparations. It also provides contract manufacturing services and veterinary products. It offers manufacturing options for product requirements like small-volume injectables in liquid form, small-volume injectables in dry powder form, eye and ear drops, intravenous fluids in poly pack and glass bottles, and veterinary medicines. The company earns the majority of its revenue from the sale of Bulk Drugs.
70GF Score

Get the complete analysis for BOM:524606

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹24.04
Price
₹20.66
GF Value